Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

48,396 stories, page 25 of 807

Advanced search

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Biohaven Ltd. (BHVN) stock price, news, quote and history

Yahoo Finance AustraliaOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech, Inc. (MBRX) stock price, news, quote and history

Yahoo Finance UKOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Sen. Warren demands answers from RFK Jr. over 'calamitous' response to cyclosporiasis outbreak

ABC News - Breaking News, Latest News and VideosOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Bonus share: Just single issue with record date this week: Pharma firm's free shares with 68% returns since IPO; ratio

LivemintOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Daewon Pharmaceutical enters the 400 billion won P-CAB market… Diversification of domestic competitive landscape expected

머니투데이Original source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Concord Biotech Bonus Issue 2026: Company fixes record date for 1:1 bonus shares

Zee BusinessOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Lab Rats series: Activating ‘natural killers’ for cancer with Zumutor

LivemintOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Experts urge Nigeria’s pharmaceutical industry to look beyond domestic market

Businessday NGOriginal source

🇮🇹3d agoResearchpoliclinico.mi.itTier 2 · Direct publisher

Salutiamo e ringraziamo Mario Nosotti, Lorenzo Rosso nuovo direttore della Chirurgia Toracica e Trapianti di Polmone

Policlinico di MilanoOriginal source

🇮🇹3d agoResearchpoliclinico.mi.itTier 2 · Direct publisher

Se hai 3 minuti, segui questi step: vota l’Archivio Storico del Policlinico di Milano e ci aiuterai a scalare la classifica dei Luoghi del Cuore FAI!

Policlinico di MilanoOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Burning Rock CEO buys 73,141 ADSs for US$618.2K

scanx.tradeOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Baropharm Set to Join KOSDAQ... Potential Expansion of Logistics Cooperation with CJ Logistics in Focus

파이낸셜뉴스Original source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Dong Nai Pharmaceutical Joint Stock Co Estimates – UPCOM:DPP

TradingViewOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

South Korea's Hanmi Pharmaceutical Launches Obesity Drug EPPE at approximately $130 for First 4 Weeks, 40% Cheaper Than Mounjaro

BigGo FinanceOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Gardiner Harris, investigative journalist: ‘No industry has been as criminal as the pharmaceutical industry’

EL PAÍS EnglishOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

🔮 39 charts on Anthropic, one-person biotech firm & cheap solar #608

Exponential View | Azeem AzharOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Heat-Sealing Pharmaceutical Films Market in Germany: Size, Trends and Forecast to 2035

IndexBoxOriginal source

🇮🇹3d agoResearchpoliclinico.mi.itTier 2 · Direct publisher

#RASSEGNASTAMPA. Ecografia intestinale, il supporto dell'AI: Mirella Fraquelli ne parla a TG4 Medicina

Policlinico di MilanoOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

OmniAb Stock: A Self-Funding Option Book On 433 Partner Programs (NASDAQ:OABI)

Seeking AlphaOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

OmniAb: A Self-Funding Option Book On 433 Partner Programs

Seeking AlphaOriginal source

🇺🇸3d agoResearchsciencedaily.comTier 2 · Direct publisher

Scientists discover a hidden driver of high cholesterol and a way to stop it

ScienceDaily Health RSSOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Carina Pedersen GoFundMe: Help After Bad Drug Invega Rebound Attack

The Oklahoma PostOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Korea biosimilar approvals stall as India and China gain U.S., EU wins

ChosunbizOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Jianzhijia Pharmaceutical Chain Group Co., Ltd. (605266.SS) Seasonal returns chart

Yahoo Finance AustraliaOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Parkinson’s developer Aspen Neuroscience (ASPE) offers IPO shares with 15 patients dosed.

Stock TitanOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Ultragenyx Pharmaceutical Inc. (RARE) Seasonal returns chart

Yahoo Finance UKOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Clinuvel Pharmaceuticals Limited (CUV.AX) stock price, news, quote and history

Yahoo Finance AustraliaOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Remibrutinib Phase 3 Results in RMS, Blood Pressure Variability Findings, and Updated Stroke Rehabilitation Guidelines

NeurologyLiveOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Blister Forming Machines Market To 2035: Pharmaceutical Demand Supports Forward Growth - News and Statistics

IndexBoxOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Kymera Therapeutics Earnings Call Highlights Biotech Momentum

TipRanksOriginal source

🌍3d agodiscoverynews.google.comTier 3 · Aggregated media

Hanmi Pharmaceutical's first glucagon-like peptide-1 (GLP-1)-based obesity treatment "Epeglenatide"

매일경제Original source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Editorial] Sweating the details in exercise oncology

Lancet OncologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Corrections] Correction to Lancet Oncol 2025; 26: 898–910

Lancet OncologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Comment] Comprehensiveness of national cancer control plans

Lancet OncologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Comment] The unfulfilled promise of effective cancer medicines priced beyond reach

Lancet OncologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Correspondence] BCG-unresponsive non-muscle-invasive bladder cancer – Authors’ reply

Lancet OncologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Comment] Iberdomide for minimal residual disease-negative myeloma—from underdog to the spotlight

Lancet OncologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Correspondence] BCG-unresponsive non-muscle-invasive bladder cancer

Lancet OncologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Comment] Rare earth elements and the fragile promise of cancer theranostics

Lancet OncologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Corrections] Correction to Lancet Oncol 2025; 26: e423–35

Lancet OncologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Correspondence] From biomarker actionability to surveillance utility in SERENA-6

Lancet OncologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Comment] From syndrome to antibody-defined autoimmune encephalitides

Lancet NeurologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[In Context] Learn From Us: stepping into the spotlight after brain injury

Lancet NeurologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[In Context] Lara M Lange

Lancet NeurologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[In Context] A Ferrier sesquicentenary

Lancet NeurologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[In Context] Katrin Andreasson: rethinking neurodegeneration

Lancet NeurologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Editorial] Neurotrauma as a chronic disease: a call for integrated care

Lancet NeurologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Correspondence] Staged bilateral focused ultrasound pallidothalamic tractotomy for Parkinson's disease – Authors' reply

Lancet NeurologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Comment] APOE, p-tau217, and cognitive impairment in diverse cohorts

Lancet NeurologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Correspondence] Staged bilateral focused ultrasound pallidothalamic tractotomy for Parkinson's disease

Lancet NeurologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Comment] Progress in exon skipping for Duchenne muscular dystrophy

Lancet NeurologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[In Context] Climate change: aggravation and adaptation in neurology

Lancet NeurologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Articles] Safety and efficacy of delpacibart zotadirsen in Duchenne muscular dystrophy mutations amenable to exon 44 skipping in the USA (EXPLORE44): a randomised, placebo-controlled, double-blind, phase 1/2 trial

Lancet NeurologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Policy View] Reframing traumatic brain injury and spinal cord injury as chronic multisystem disorders: toward integrated, long-term care

Lancet NeurologyOriginal source

🇺🇰3d agoResearchthelancet.comTier 2 · Direct publisher

[Personal View] Antibody-mediated encephalitides: distinct diseases with transdisciplinary implications

Lancet NeurologyOriginal source

🇯🇵3d agoIndustrysanten.comTier 1 · Company source

眼瞼下垂をテーマにしたプレスセミナーを開催

Santen Pharmaceutical NewsOriginal source

🇯🇵3d agoIndustrysanten.comTier 1 · Company source

令和8年熊本地震に対する義援金の寄付について

Santen Pharmaceutical NewsOriginal source

🇯🇵3d agoIndustrysanten.comTier 1 · Company source

サステナビリティレポート2026を発行

Santen Pharmaceutical NewsOriginal source

🇯🇵3d agoIndustrysanten.comTier 1 · Company source

当社名をかたるSNSなりすましアカウントに関する注意喚起

Santen Pharmaceutical NewsOriginal source

🇯🇵3d agoIndustrysanten.comTier 1 · Company source

「健康経営優良法人2026（大規模法人部門）」に認定

Santen Pharmaceutical NewsOriginal source